Estrogen inhibits bladder overactivity in rats with cyclophosphamide‐induced cystitis via downregulating the expression of P2X3 receptors in bladder epithelium cells-Reference-Cited by-同舟云学术

Estrogen inhibits bladder overactivity in rats with cyclophosphamide‐induced cystitis via downregulating the expression of P2X3 receptors in bladder epithelium cells

Published:2021-10-07 Issue:1 Volume:41 Page:174-187
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Liu Xin¹^ORCID,Yang Yang¹,Gao Ye¹,Zhang Hengshuai¹,Zhu Jingzhen¹,Dong Xingyou¹,Xu Jie¹^ORCID

Affiliation:

1. Department of Urology, Second Affiliated Hospital Army Medical University Chongqing Shapingba P.R. China

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.24811

Reference28 articles.

1. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society

2. Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group

3. Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment

4. Intravesical treatments of bladder pain syndrome/interstitial cystitis

5. Oestrogens and overactive bladder

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interconnected microbiomes—insights and innovations in female urogenital health;The FEBS Journal;2024-07-30

2. The microbiota in patients with interstitial cystitis/bladder pain syndrome: a systematic review;BJU International;2024-06-18

3. Therapeutic Effects of AF219 on Interstitial Cystitis/Bladder Pain Syndrome Induced by Cyclophosphamide or Water Avoidance Stress in Rats;International Urogynecology Journal;2024-02-20

4. Interaction of LPA1 and P2X3 Receptors in DRG Neurons: Implications for Cyclophosphamide-Induced Bladder Pain Syndrome in Mice;J BIOL REG HOMEOS AG;2024